Swapnil Bhargava
Direttore Tecnico/Scientifico/R&S presso CG ONCOLOGY, INC.
Profilo
Swapnil Bhargava is currently the Chief Technical Officer at CG Oncology, Inc. He previously worked as the SVP-CMC Development & GMP Manufacturing at AbCellera Biologics, Inc. and as the VP-Drug Substance Process Development at Seagen Inc. Dr. Bhargava holds a doctorate degree from the University of Maryland and a graduate degree from the Indian Institute of Technology Delhi.
Posizioni attive di Swapnil Bhargava
| Società | Posizione | Inizio |
|---|---|---|
| CG ONCOLOGY, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2023 |
Precedenti posizioni note di Swapnil Bhargava
| Società | Posizione | Fine |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | - |
| ABCELLERA BIOLOGICS INC. | Corporate Officer/Principal | - |
Formazione di Swapnil Bhargava
| University of Maryland | Doctorate Degree |
| Indian Institute of Technology Delhi | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| ABCELLERA BIOLOGICS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Borsa valori
- Insiders
- Swapnil Bhargava
